Literature DB >> 507513

Aspergillosis and atopy in cystic fibrosis.

L A Nelson, M L Callerame, R H Schwartz.   

Abstract

Forty-six patients with cystic fibrosis (CF) were studied for colonization and sensitization by Aspergillus organisms. The fungus was cultured from 21 of 37 (57%) patients who produced sputum. The non-CF sputum isolation rate was 6.5%. Sputum hyphae were seen in 95% of patients with positive cultures. Sputum eosinophilia accompanied colonization by Aspergillus. Aspergillus precipitins were found in 37% of CF patients; positive immediate skin tests were found in 39%. "Atopy" defined by skin test criteria was found in 46%. All of these findings were more common in patients with more severe disease (p less than 0.05). CF patients had predominant mold sensitivity in contrast to predominant pollen sensitivity in a control group of asthmatic subjects. Serum IgE concentrations were increased in 22% of CF patients. CF patients who had increased serum concentrations of IgE were more likely to have a family history of atopy. Wheezing was more common in those who were atopic, especially the group with predominant mold sensitivity who had more severe disease. Four patients fulfilled the diagnostic criteria for allergic bronchopulmonary aspergillosis (ABPA) during the time of study and follow-up. A fifth patient had ABPA diagnosed before the study. The incidence of ABPA during a 2-yr period in our CF population was 11%.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 507513     DOI: 10.1164/arrd.1979.120.4.863

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  38 in total

1.  Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis.

Authors:  P W Miller; A Hamosh; M Macek; P A Greenberger; J MacLean; S M Walden; R G Slavin; G R Cutting
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Authors:  J Periselneris; L Nwankwo; S Schelenz; A Shah; D Armstrong-James
Journal:  J Antimicrob Chemother       Date:  2019-06-01       Impact factor: 5.790

Review 3.  Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Authors:  A P Knutsen; R G Slavin
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 4.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis.

Authors:  P E Verweij; J F Meis; J Sarfati; J A Hoogkamp-Korstanje; J P Latgé; W J Melchers
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

Review 6.  Allergic bronchopulmonary aspergillosis.

Authors:  Richard B Moss
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

7.  Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis.

Authors:  J Efthimiou; M E Hodson; P Taylor; A G Taylor; J C Batten
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

8.  Mycobacterial isolations in young adults with cystic fibrosis.

Authors:  M J Smith; J Efthimiou; M E Hodson; J C Batten
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

9.  Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium.

Authors:  R Amitani; G Taylor; E N Elezis; C Llewellyn-Jones; J Mitchell; F Kuze; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 10.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.